Back
42
Day Range
$11.00
$11.00
52-Week Range
$9.50
$18.55
Volume
130
50D / 200D Avg
$12.38
/
$14.80
Prev Close
$11.00
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.3 | 0.4 |
| P/B | 0.2 | 2.9 |
| ROE % | -46.6 | 3.9 |
| Net Margin % | -155.0 | 3.8 |
| Rev Growth 5Y % | 17.8 | 10.0 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$0.00
$0.00 – $0.00
|
3.87B | 0 |
| FY2026 |
$0.00
$0.00 – $0.00
|
3.55B | 0 |
No quarterly estimates available
Dividend History
Yield
0.01%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 17.77% annually over 5 years — strong growth
Earnings declined -1077.00% over the past year
Debt/Equity of 0.20 — conservative balance sheet
Generating 343.10M in free cash flow
PEG of 0.00 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 28.17%
Growth
Revenue Growth (5Y)
17.77%
Revenue (1Y)-10.40%
Earnings (1Y)-1077.00%
FCF Growth (3Y)-26.67%
Quality
Return on Equity
-46.55%
ROIC4.57%
Net Margin-155.00%
Op. Margin17.91%
Safety
Debt / Equity
0.20
Current Ratio3.40
Interest Coverage12.08
Valuation
P/E Ratio
-0.30
Forward P/EN/A
P/B Ratio0.19
EV/EBITDA3.95
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -10.40% | Revenue Growth (3Y) | -4.05% |
| Earnings Growth (1Y) | -1077.00% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 17.77% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3.23B | Net Income (TTM) | -5.01B |
| ROE | -46.55% | ROA | -45.06% |
| Gross Margin | 61.76% | Operating Margin | 17.91% |
| Net Margin | -155.00% | Free Cash Flow (TTM) | 343.10M |
| ROIC | 4.57% | FCF Growth (3Y) | -26.67% |
| Safety | |||
| Debt / Equity | 0.20 | Current Ratio | 3.40 |
| Interest Coverage | 12.08 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.30 | Forward P/E | N/A |
| P/B Ratio | 0.19 | P/S Ratio | 0.46 |
| PEG Ratio | 0.00 | Forward PEG | N/A |
| EV/EBITDA | 3.95 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 23.03% | ||
| Market Cap | 1.49B | Enterprise Value | 2.29B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.23B | 3.61B | 3.51B | 3.23B | 1.68B |
| Net Income | -5.01B | 513.00M | -3.85B | 394.00M | 341.00M |
| EPS (Diluted) | -34.79 | 3.78 | -28.44 | 2.91 | 2.97 |
| Gross Profit | 2.00B | 2.14B | 1.98B | 1.78B | 1.05B |
| Operating Income | 579.03M | 783.00M | -3.59B | 654.00M | 435.38M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 11.12B | 17.45B | 16.33B | 20.55B | 19.43B |
| Total Liabilities | 3.23B | 3.81B | 3.61B | 3.81B | 4.09B |
| Shareholders' Equity | 7.89B | 13.64B | 12.72B | 16.74B | 15.32B |
| Total Debt | 1.61B | 2.09B | 2.09B | 2.23B | 2.48B |
| Cash & Equivalents | 809.00M | 1.14B | 861.00M | 578.00M | 630.09M |
| Current Assets | 2.09B | 2.36B | 1.91B | 1.57B | 1.41B |
| Current Liabilities | 615.00M | 705.00M | 557.00M | 621.00M | 954.33M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#413 of 827
Recent Activity
Entered
Deep Value Investing (Seth Klarman)
Mar 24, 2026